What Is IGF-1 (Insulin-like Growth Factor 1)?

IGF-1 stands for insulin-like growth factor 1. It is a protein produced mainly by the liver, and its production is prompted in large part by growth hormone released from the pituitary gland at the base of the brain. In effect, IGF-1 carries out many of the downstream signals associated with growth hormone as it circulates through the body.

Its name comes from a structural resemblance to insulin, though IGF-1 has its own distinct roles related to growth and tissue maintenance. Levels of IGF-1 naturally shift across the lifespan, tending to be highest during periods of rapid growth and settling into different patterns in adulthood, which is part of why clinicians always read it against a person's stage of life.

Growth hormone is released in short pulses and swings quickly throughout the day, which makes a single growth hormone measurement hard to interpret on its own. IGF-1 tends to be steadier because it reflects growth hormone activity integrated over a longer window. That stability is a big reason clinicians often turn to IGF-1 when they want a practical, general read on the growth hormone system.

Clinicians may consider IGF-1 as part of a broader workup that a person's history and symptoms point toward. It is generally read together with other information rather than alone, because the growth hormone system interacts with many factors. As always, the marker is a tool a clinician uses to help evaluate a picture, not something that establishes a conclusion by itself.

IGF-1 sometimes comes up in discussions about aging and optimization, since the growth hormone system changes as people move through adulthood and some people are curious about tracking markers tied to it. Framed as wellness and self-knowledge, following a marker like IGF-1 can give a person and their clinician a shared reference point for conversation.

It helps to keep expectations realistic here. IGF-1 is one narrow window into a complex system, and it does not summarize how well someone is aging or predict anything on its own. Reading it as a single, decisive number tends to mislead, whereas reading it as one input among many, in context, keeps it useful.

IGF-1 is associated with the overall activity of the growth hormone system. Clinicians describe patterns in which IGF-1 tends to run relatively higher or relatively lower, and those patterns are linked to how growth hormone is being produced and how the body is responding to it.

A number of everyday factors can influence IGF-1, including age, nutrition, and overall health status, so a result is best understood as a pattern rather than a fixed trait. For that reason clinicians regard IGF-1 as one thread in a larger story and interpret it alongside a person's history and any related markers.

IGF-1 is measured from a routine blood sample, typically collected at a patient service center and sent to a laboratory. Preparation is usually straightforward, though a clinician may offer guidance about timing or about any medications that could be relevant.

Once results are back, a clinician interprets them in the context of age, symptoms, health history, and any other markers ordered. The result belongs in a conversation with that clinician, who is the person able to weigh it properly and decide whether anything further is worth exploring.